Enantio- and Diastereoselective Nitro-Mannich Reaction of α-Aryl

Apr 18, 2017 - Klausen, Kennedy, Hyde, and Jacobsen. 2017 139 ... Quinine-Based Trifunctional Organocatalyst for Tandem Aza-Henry Reaction-Cyclization...
0 downloads 0 Views 537KB Size
Download PDF
Article pubs.acs.org/joc

Enantio- and Diastereoselective Nitro-Mannich Reaction of α‑Aryl Nitromethanes with Amidosulfones Catalyzed by Phase-Transfer Catalysts Ning Lu, Ruxu Li, Zhonglin Wei, Jungang Cao, Dapeng Liang, Yingjie Lin,* and Haifeng Duan* Department of Organic Chemistry, College of Chemistry, Jilin University, 2699 Qianjin Street, Changchun 130012, China S Supporting Information *

ABSTRACT: A high-yield, highly diastereo- and enantioselective nitro-Mannich reaction of α-aryl nitromethanes with amidosulfones catalyzed by a novel chiral phase-transfer catalyst, bearing multiple H-bonding donors, derived from quinine was developed. A variety of α-aryl nitromethanes and amidosulfones were investigated; and the corresponding products were obtained in excellent yields with excellent diastereo- and enantioselectivities (up to 99% yield, > 99:1 dr and >99% ee). As a demonstration of synthetic utility, the resulting β-nitroamines could be converted to corresponding meso-symmetric and optically pure unsymmetric anti-1,2-diarylethylenediamines.

■

INTRODUCTION Vicinal diamines are one of most important core structures of many drugs. Moreover, they are also used as chiral ligands and have been widely used in asymmetric catalysis.1 As a result, chiral vicinal diamines have been the subject of research, and a number of highly stereoselective synthetic methodologies have been developed.2 Among structurally diverse vicinal diamines, optically active 1,2-diarylethylenediamines have been widely used to prepare chiral ligands, organocatalysts, and biologically active molecules.3 Despite their utility, effective methods for the preparation of optically pure 1,2-diarylethylenediamines are still limited.1b Among these existing synthetic methodologies, cumbersome asymmetric synthesis started from chiral starting materials and chiral resolution of a racemic multisteps reaction product using an appropriate chiral reagent are two traditional strategies.2b,c,4 However, expensive prices of chiral materials and a limited range of substrates limited the application of these two strategies. Recently, an attractive strategy which can generate a wide scope of 1,2-diarylethylenediamines, catalytic asymmetric nitro-Mannich reaction of aromatic aldimines with α-aryl nitromethanes followed by the reduction of nitro group, has been developed.5 Although a series of asymmetric nitroMannich reaction of nitromethane and its alkyl congeners have been successfully reported,6 to the best of our knowledge, the successful asymmetric nitro-Mannich reactions using α-aryl nitromethanes as substrates are rare. There are two research efforts that are impressive. One of them was reported by Johnston and co-workers in 2011.7 In this work, chiral bisamidine-quinoline catalysts were found to be efficient in the asymmetric addition of α-aryl nitromethanes to N-Boc aldimines, and azaHenry adducts were obtained in good yields with good to high diastereo- and enantioselectivities (2:1→20:1 dr and 76−93% ee) (Scheme 1a). In another work reported by Ooi’s group, chiral ammonium betaines were successfully used to catalyze © 2017 American Chemical Society

the highly diastereo- and enantioselective nitro-Mannich reaction of α-aryl nitromethanes with N-Boc imines. However, the reaction should be carried out under stringent anhydrous conditions8 (Scheme 1b). Although these elegant works have been reported, in terms of α-aryl nitromethanes and the corresponding adducts containing acidic hydrogen atoms at benzyl position, developing an efficient base-catalyzed highly diastereoand enantioselective catalytic system is still challenging and desirable.8,9 Amidosulfones due to their broad range and good stability compared with the N-Boc imines have been used in several asymmetric catalytic reactions.6c,d,10 In our previous work, amidosulfones successfully reacted with nitroalkanes in the presence of the bifunctional phase transfer catalyst 2a.11a Enlightened by this work and as a continuation of our studies on developing bifunctional chiral phase transfer catalysts bearing multiple H-bond donors, we anticipated that a similar protocol could be applied to the asymmetric nitro-Mannich reaction of α-aryl nitromethanes, albeit controlling diastereoand enantioselectivity that would be significantly more challenging. Herein, we would like to report an efficient and highly diastereo- and enantioselective nitro-Mannich reaction of N-Boc amidosulfones with α-aryl nitromethanes catalyzed by a novel phase transfer catalyst bearing multiple H-bonding donors. (Scheme 1c).

■

RESULTS AND DISCUSSION In order to evaluate the catalytic potential of chiral phase transfer phase catalysts in the asymmetric nitro-Mannich reaction of α-aryl nitromethanes, we initially chose the reaction of Received: February 8, 2017 Published: April 18, 2017 4668

DOI: 10.1021/acs.joc.7b00306 J. Org. Chem. 2017, 82, 4668−4676

Article

The Journal of Organic Chemistry

Scheme 1. Previously Reported Asymmetric Nitro-Mannich Reaction of N-Boc Imines with α-Aryl Nitromethanes, and a New Method with Respect to This Reaction

amidosulfone 4a with α-phenyl nitromethane 5a as a model reaction (Table 1) and investigated the catalytic activity of catalyst 2a. Gratifyingly, in the presence of KOH and toluene at −30 °C, catalyst 2a showed a good asymmetric catalytic activity, and the desired adduct 6aa (1S, 2R) was isolated in 67% yield with 96:4 dr and 71% ee (entry 1), The product configuration is in agreement with the data reported in the literature.7 In further screening of bases, K2CO3 and Cs2CO3 have no apparent improvement in the yield and ee value of the product (entries 2−3). Surprisingly, when LiOH was employed in the reaction, the yield of 6aa increased from 67% to 93%, and the dr and ee values were also improved slightly (entry 4). Inspired by these good results, we turned our attention on the modification of catalyst on the basis of catalyst 2a. To this end, catalyst 2b was synthesized using sterically hindered 3,5-di-tertbutyl benzyl in place of benzyl on the nitrogen atom of quinine according to the procedure described in our previous work.11 Remarkably, catalyst 2b exhibited an improved asymmetric catalytic activity and stereoselectivity in the presence of LiOH and using toluene as the reaction solvent (entry 5). In addition, well-behaved catalyst 3, which was developed by Dixon group and exhibited excellent asymmetric activity in the nitroMannich reaction of nitromethane, was also evaluated under the identical reaction conditions. Compared with catalyst 2b, it did not have a positive impact on the yield and enantioselectivity (entry 6), and the relative and absolute configurations of the product is consistent. In subsequent screening of solvents and reaction temperatures, dichloromethane used as the solvent have a beneficial effect on the enantioselectivity of adduct 6aa, and the ee value increased from 87% to 98% at −30 °C.

However, the yield decreased to 85% (entry 7). On the contrary, chloroform led to a high yield but ee value decreased slightly at −30 °C (entry 8). Lowering the reaction temperature to −40 °C further improved the reaction results. In this case, catalyst 2b exhibited excellent catalytic activity and diastereoand enantiocontrolling ability (entry 9, 99% yield, 99:1 dr, 99% ee). In the final optimization of loadings of catalyst 2b and substrate 4a, lowering catalyst 2b loadings led to a decrease in the yield (entries 10 and 11). Satisfyingly, reducing the amounts of substrate 4a from 5 to 1.5 equiv, we can still get the best result (entry 12). However, performing this reaction with 1.1 equiv of 4a led to a slight decline in the yield (entry 13). After a series of screenings and optimizations, eventually, the optimal reaction conditions were identified as follows: 1.5 equiv of 4a, 5 mol% of catalyst 2b, 5 equiv of LiOH, CHCl3 used as solvent, the reaction temperature of −40 °C, and 12 h. With the optimal conditions in hand, the scope of the reaction with respect to amidosulfones and α-aryl nitromethanes were investigated, and corresponding results were summarized in Table 2. For all cases, excellent yields (90−99%) and excellent diastereo- and enantioselectivities (93:7−99:1 dr, 91−99% ee) were obtained across the series. In these cases, a variety of amidosulfones derived from aromatic aldehydes proved effective, with an electron-donating or electron-withdrawing group in ortho-, meta- as well as para-position all being well-tolerated with excellent reactivity and stereoseclectivities observed (entries 1−12). In spite of this, in terms of methoxyl-substituted amidosulfones, the position of methoxy have a slight effect on the diastereoselectivity. For example, compared with substrates 4c and 4j, meta-methoxy-substituted amidosulfone 4669

DOI: 10.1021/acs.joc.7b00306 J. Org. Chem. 2017, 82, 4668−4676

Article

The Journal of Organic Chemistry Table 1. Optimization of Reaction Conditionsa

entry

cat.

solvent

base

temp (°C)

yieldb (%)

d.r.c

eed

1 2 3 4 5 6 7 8 9 10e 11f 12g 13h

2a 2a 2a 2a 2b 3 2b 2b 2b 2b 2b 2b 2b

toluene toluene toluene toluene toluene toluene CH2Cl2 CHCl3 CHCl3 CHCl3 CHCl3 CHCl3 CHCl3

KOH K2CO3 Cs2CO3 LiOH LiOH LiOH LiOH LiOH LiOH LiOH LiOH LiOH LiOH

−30 −30 −30 −30 −30 −30 −30 −30 −40 −40 −40 −40 −40

67 43 56 93 98 84 85 99 99 85 95 99 92

96:4 94:6 98:2 98:2 98:2 97:3 99:1 99:1 99:1 98:2 99:1 99:1 99:1

71 70 68 74 87 72 98 95 99 91 98 99 99

catalysts, respectively (Scheme 2). Compared with catalyst 2b, catalyst 2c, in which the hydroxyl group was protected by methylation, has lower catalytic activity and stereocontrol ability. Similarly, catalyst 1, in absence of a quaternary ammonium center, exhibited a significant decrease in catalytic activity and diastereo- and enantiocontrol ability, and configurations of the product is consistent. These results supported synergistic catalysis of bifunctional catalysts and indicated that both the hydroxy on the phenylglycinol moiety and the quaternary ammonium center were crucial to achieve excellent catalytic activity and stereoselectivity in this asymmetric nitro-Mannich reaction. To explain the stereoselectivity of the reaction, a possible transition-state model was proposed (Figure 1). The ammonium motif pairs with the nitro compounds by electrostatic interaction and the urea motif captures the N-Boc imines by hydrogen bond (HB) interaction. Therefore, a highly ordered transition state is formed and the nitro compounds can attack the N-Boc imines from the Re face. The universality of the present system was further demonstrated by the application to aliphatic amidosulfone, excellent levels of diastereo- and enantioselectivity were also obtained with amidosulfone 4q as a substrate (Scheme 3a). Finally, the applicability of this protocol was demonstrated by the derivatization of optically pure 6aa and 6ea. As shown in Scheme 3b, 6aa could be readily derivatized into meso-symmetric 1,2diarylethylenediamine 8aa, and 6aa could be coverted to unsymmetric anti-1,2-diarylethylenediamine 8ea via a nickelboride mediated reduction of nitro-group followed by the removal of Boc in the presence of trifluoroacetic acid.

■

a

Unless otherwise noted, reactions were carried out with 0.1 mmol of 4a, 0.5 mmol of 5a, and 5 mol% of catalyst in 1.0 mL of solvent. bYield of isolated product. cDiastereomeric ratios determined by 1H NMR. d Determined by HPLC using a chiral stationary phase. e1 mol% catalyst was used. f2.5 mol% catalyst was used. g0.15 mmol of 5a was used. h0.11 mmol of 5a was used.

CONCLUSIONS In summary, we have developed an efficient and highly diastereo- and enatioselective nitro-Mannich reaction of α-aryl nitromethanes with stable amidosulfones in place of N-Boc imines, which was catalyzed by a novel bifunctional phasetransfer catalyst bearing multiple H-bonding donors. A variety of α-aryl nitromethanes and amidosulfones were investigated, and corresponding products were obtained in excellent yields with excellent diastereo- and enantioselectivities. Using this asymmetric catalytic protocol, optically pure unsymmetric and meso-symmetric 1,2-diarylethylenediamines could be synthesized. Detail mechanism study on this reaction and further application of this kind of bifunctional phase transfer catalysts bearing multiple H-donors are underway in our laboratory.

4d afforded adduct 6da with a slightly decreased dr (93:7) (entry 2 and 9 vs 3). Unfortunately, the desired product was not detected when the aminosulfone derived from 4-dimethylamino benzaldehyde was used as the substrate. Moreover, polycyclic aromatic and heteroaromatic substrates were also proven effective (entries 13−15). Next, we set out to investigate the generality of the reaction with other α-aryl nitromethanes. Pleasingly, the present catalytic system was applicable to a range of α-aryl nitromethanes with an electron-withdrawing or electron-donating group, and corresponding products were yielded in high yields (94−99%) with excellent dr and ee values (93:7−99:1 dr, 91−99% ee, entries 16−19). In addition, 1-(2naphthyl) nitromethane 5g used as the substrate also proved effective (entry 21, 98:2 dr and 96% ee). Similarly, arbitrary combinations of amidosulfones and α-aryl nitromethanes were well accommodated (entries 22 and 23), and products containing underlying symmetric 1,2-diarylethylenediamines scaffold could be obtained in high yields (entry 24). Subsequently, we have successfully conducted a gram scale reaction of 4a with 5a under standard conditions, and optically pure 6aa was obtained after column chromatography (1.03 g, 99% yield, 99:1 dr and 99% ee, entry 25). To investigate the role of the quaternary ammonium center and multiple H-bonding donors in this kind of bifunctional catalysts, and to test their synergistic catalysis, two control experiments were performed using compounds 2c and 1 as

■

EXPERIMENTAL SECTION

General Information. Unless otherwise stated, all reagents were purchased from commercial suppliers and used without purification. All solvents were obtained from commercial sources and were purified according to standard procedures. For thin-layer chromatography (TLC), silica gel plates (HSGF 254) were used and compounds were visualized by irradiation with UV light. Purification of reaction products was carried out by flash column chromatography using silica gel (200−300 mesh).1H, 13C NMR, and 19F NMR spectra were recorded on a Varian Mercury-300BB (300 MHz), a Bruker NMR Spectrometer (400 MHz), or a Bruker NMR Spectrometer (500 MHz). All chemical shifts (δ) were given in ppm. Chemical shifts (δ ppm) are relative to the resonance of the deuterated solvent as the internal standard (CDCl3, δ 7.26 ppm for proton NMR, δ 77.2 ppm for carbon NMR; CD3OD-d4, δ 3.31 ppm for proton NMR, δ 49.0 ppm for carbon NMR; DMSO-d6, δ 2.50 ppm for proton NMR, δ 39.5 ppm for carbon NMR). Data are presented as follows: chemical shift, integration, multiplicity (br = broad, s = singlet, d = doublet, t = triplet, 4670

DOI: 10.1021/acs.joc.7b00306 J. Org. Chem. 2017, 82, 4668−4676

Article

The Journal of Organic Chemistry Table 2. Substrate Scope of Nitro-Mannich Reaction Using Catalyst 2ba

entry

4

Ar1

5

Ar2

6

yieldb (%)

d.r.c

eed (%)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25g

4b 4c 4d 4e 4f 4g 4h 4i 4j 4k 4l 4m 4n 4o 4p 4a 4a 4a 4a 4a 4a 4j 4j 4h 4a

o-FC6H4 o-MeOC6H4 m-MeOC6H4 m-ClC6H4 p-FC6H4 p-ClC6H4 p-BrC6H4 p-MeC6H4 p-MeOC6H4 p-CF3C6H4 p-NO2C4H6 p-CNC4H6 2-naphthyl 2-furyl 2-thienyl Ph Ph Ph Ph Ph Ph p-MeOC6H4 p-MeOC6H4 p-BrC6H4 Ph

5a 5a 5a 5a 5a 5a 5a 5a 5a 5a 5a 5a 5a 5a 5a 5b 5c 5d 5e 5f 5g 5b 5d 5d 5a

Ph Ph Ph Ph Ph Ph Ph Ph Ph Ph Ph Ph Ph Ph Ph o-FC6H4 m-MeOC6H4 p-BrC6H4 p-MeC6H4 p-MeOC6H4 2-naphthyl o-FC6H4 p-BrC6H4 p-BrC6H4 Ph

6ba 6ca 6da 6ea 6fa 6ga 6ha 6ia 6ja 6ka 6la 6ma 6na 6oa 6pa 6ab 6ac 6ad 6ae 6af 6ag 6jb 6jd 6hd 6aa

99 99 99 99 99 99 97 99 99 99 93 97 90 99 99 94 99 99 99 99 99 98 96 99 99

>99:1 99:1 93:7 >99:1 98:2 >99:1 >99:1 >99:1 99:1 >99:1 94:6 98:2 >99:1 98:2 97:3 93:7 99:1 98:2 >99:1 99:1 98:2 99:1 97:3 97:3 99:1

99e 98 98e 98 98f 99f 99e 96f 98f 98f 99 95 97f 99e 92 99e 98e 99e 99e 91e,f 96e,f 98e 96e 99 99e

a Unless otherwise noted, reactions were carried out with 0.1 mmol of 4,0.15 mmol of 5, and 5 mol% of 2b in 1.0 mL of CHCl3. bYield of isolated product. cDiastereomeric ratios determined by HPLC. dDetermined by HPLC using a chiral stationary phase. e,fAbsolute and relative configurations of anti-isomers were determined by comparison to literature data.7,8 gThe reaction was performed with 3.0 mmol of 4a, 4.50 mmol of 5a, and 5 mol% of 2b in 30 mL of CHCl3.

Scheme 2. Control Experiment for Mechanistic Study

Figure 1. Proposed transition state model leading to anti-adducts. were prepared using reported procedures from corresponding aldehydes.13 Nitro compounds were prepared by following the literature.14 All aminoalcohols was purchased from commercial suppliers and used directly. Preparation and Characterization of the Chiral Ureas with Multiple Hydrogen-Bonding Donors. General Procedure. N,N′carbonyldiimidazole (165 mg, 1.02 mmol, 1.1 equiv) was dissolved in anhydrous THF, a solution of 9-amino(9-deoxy)epiquine (300 mg, 0.93 mmol, 1 equiv) in THF (5 mL) was added dropwise in 1 h, the reaction mixture was stirred for another 1 h. Then aminoalcohol (1.1 equiv) and triethylamine (142 μL, 1.1 equiv) were added in one portion respectively, the resulting mixture was stirred until TLC showed that the reaction was completed. The mixture was diluted with

q = quartet, m = multiplet) and coupling constant in Hertz (Hz). Mass spectra were recorded on the Bruker Agilent1290 MicrOTOF Q II. Melting points were measured on a melting point apparatus and were uncorrected. The ee values determination was carried out using chiral HPLC (Waters) with Chiracel IA-3 column, Chiracel IC-3 column, and Chiracel AD-H column. Optical rotations were measured on a Shanghai ShenGuang SGW-2 Polarimeter at λ = 589 nm. Optical rotations are reported as follows: [α]D20 (c = g/100 mL, solvent). Starting Materials. 9-Amino(9-deoxy)epicinchona alkaloids of quinine were prepared according to reported procedure.12 All amidosulfones 4671

DOI: 10.1021/acs.joc.7b00306 J. Org. Chem. 2017, 82, 4668−4676

Article

The Journal of Organic Chemistry

Preparation and Characterization of the Chiral PTC with Multiple Hydrogen-Bonding Donors. General Procedure. Under N2 protection, 9-amino(9-deoxy)epiquine-derived urea 1 (150 mg, 1 equiv) was dissolved in THF (0.1 M), then benzyl bromide (1.1 equiv) was added, the mixture was heated to reflux, after 12 h the mixture was concentrated and purified by flash chromatography. Catalyst 2a. Obtained according to the general procedure, the crude product was purified by flash chromatography (Et2O/MeOH = 10:1).

Scheme 3. Reaction of Aliphatic Amidosulfone with α-Phenyl Nitromethane and Derivatization of 6aa and 6ea To the Corresponding 1,2-Diarylethylenediamine 8aa and 8ea

Light yellow solid, 87 mg, 43% yield, mp = 178−179 °C (decomp.), [a]D25 = −44.4 (c = 0.5, CHCl3). 1H NMR (300 MHz, CD3OD) δ 8.77 (d, J = 4.1 Hz, 1H), 8.01 (d, J = 9.2 Hz, 1H), 7.81−7.63 (m, 2H), 7.60−7.32 (m, 7H), 7.28−7.14 (m, 2H), 7.13−6.95 (m, 2H), 6.32 (d, J = 10.6 Hz, 1H), 5.98−5.71 (m, 1H), 5.34−5.05 (m, 3H), 5.03−4.96 (m, 1H), 4.44−4.24 (m, 1H), 4.20−3.88 (m, 4H), 3.81−3.37 (m, 5H), 2.84−2.56 (m, 1H), 2.25−1.72 (m, 5H), 1.22−1.07 (m, 1H). 13C NMR (101 MHz, CD3OD) δ 160.6, 158.7, 148.6, 148.3, 145.6, 145.4, 142.2, 137.5, 134.7, 131.9, 131.5, 130.4, 129.4, 128.8, 128.4, 128.2, 128.0, 127.4, 124.2, 124.0, 120.6, 118.2, 102.6, 69.4, 67.3, 66.4, 61.6, 58.1, 56.6, 51.5, 50.4, 38.6, 28.7, 28.1, 25.5. HRMS (ESI): calculated for C36H41N4O3 [M−Br]+: 577.3173, found 577.3167. Catalyst 2b. Obtained according to the general procedure, the crude product was purified by flash chromatography (Et2O/MeOH = 10:1).

36 mL ethyl acetate, then washed with water (10 × 15 mL), the organic phase was dried over Na2SO4. The solvent was removed under reduced pressure and the crude product was purified by flash chromatography (ethyl acetate/MeOH = 10:1). Urea 1 Derived from Quinine and L-Phenylglycinol/[(S)-(+)-2Phenylglycinol].

Light yellow solid, 334 mg, 74% yield, mp = 109−111 °C, [a]D25 = −21 (c = 0.33, CHCl3). 1H NMR (300 MHz, CDCl3) δ 8.64 (d, J = 4.6 Hz, 1H), 7.99 (d, J = 9.2 Hz, 1H), 7.64 (d, J = 2.3 Hz, 1H), 7.35 (dd, J = 9.1, 2.6 Hz, 1H), 7.30−7.25 (m, 3H), 7.21−7.11 (m, 3H), 6.25 (br. s, 1H), 5.87 (br. s, 1H), 5.79−5.53 (m, 1H), 5.22 (br. s, 1H), 5.09−4.86 (m, 2H), 4.64 (d, J = 5.2 Hz, 1H), 3.92 (s, 3H), 3.73 (d, J = 4.8 Hz, 2H), 3.16 (br. s, 2H), 3.03−2.85 (m, 1H), 2.75−2.36 (m, 2H), 2.24 (br. s, 1H), 1.72−1.30 (m, 4H), 1.01−0.77 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 158.2, 157.9, 147.5, 144.7, 141.2, 140.9, 140.5, 131.6, 128.9, 128.6, 128.4, 127.4, 126.7, 121.8, 114.9, 102.0, 66.9, 60.5, 57.2, 55.7, 55.5, 40.7, 39.2, 34.4, 27.5, 27.3, 26.0. HRMS (ESI): calculated for C29H35N4O3 [M+H]+: 487.2704, found 487.2695. Urea Derived from Quinine and (1S)-2-Methoxy-1-phenylethanamine.

Light yellow solid, 115 mg, 48% yield, mp = 147−148 °C (decomp.), [a]D25 = −90.8 (c = 0.5, CHCl3). 1H NMR (500 MHz, CD3OD) δ 8.72 (d, J = 45.6 Hz, 1H), 8.00 (d, J = 9.1 Hz, 1H), 7.81− 7.59 (m, 3H), 7.55−7.43 (m, 1H), 7.30 (s, 2H), 7.13 (s, 2H), 7.02− 6.58 (m, 3H), 6.32 (d, J = 10.0 Hz, 1H), 6.06−5.81 (m, 1H), 5.21 (dd, J = 19.5, 14.3 Hz, 2H), 4.91 (d, J = 11.8 Hz, 3H), 4.80 (br, J = 34.7 Hz, 1H), 4.34 (s, 1H), 4.19 (s, 1H), 4.06 (s, 3H), 3.70−3.34 (m, 5H), 2.70 (br, 1H), 2.25−1.72 (m, 4H), 1.39 (s, 2H), 1.34 (s, 18H), 1.14 (d, J = 13.3 Hz, 1H). 13C NMR (126 MHz, CD3OD) δ 160.6, 158.7, 153.2, 148.6, 146.0, 145.5, 141.9, 138.0, 131.9, 129.3, 129.0, 128.7, 128.2, 128.1, 127.2, 125.8, 124.3, 120.8, 118.2, 102.4, 70.2, 68.0, 66.6, 61.2, 57.7, 56.6, 51.0, 50.2, 38.6, 35.8, 31.8, 29.1, 28.1, 25.6. HRMS (ESI): calculated for C44H57N4O3 [M−Br]+: 689.4425, found 689.4425. Catalyst 2c. Obtained according to the general procedure, the crude product was purified by flash chromatography (EA/MeOH = 10:1).

Light yellow solid, 306 mg, 66% yield, mp = 90−91 °C, [a]D25 = −25.2 (c = 0.5, CHCl3). 1H NMR (300 MHz, CDCl3) δ 8.69 (d, J = 4.6 Hz, 1H), 8.01 (d, J = 9.2 Hz, 1H), 7.66 (d, J = 2.6 Hz, 1H), 7.37 (dd, J = 9.2, 2.7 Hz, 1H), 7.28 (d, J = 1.4 Hz, 1H), 7.25−7.17 (m, 5H), 6.34 (br.s, 1H), 5.78−5.59 (m, 1H), 5.51 (d, J = 6.7 Hz, 1H), 5.25 (br.s, 1H), 5.07−4.91 (m, 2H), 4.83 (dd, J = 11.4, 6.2 Hz, 1H), 3.95 (s, 3H), 3.57−3.40 (m, 2H), 3.37−3.14 (m, 6H), 2.90−2.64 (m, 2H), 2.45− 2.25 (m, 1H), 1.77−1.59 (m, 3H), 1.53−1.37 (m, 1H), 1.06−0.94 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 157.7, 147.4, 145.7, 144.6, 141.1, 140.6, 131.5, 129.8, 128.4, 128.2, 127.4, 127.1, 126.5, 121.5, 114.5, 102.0, 75.6, 71.7, 60.0, 58.6, 55.7, 55.5, 53.9, 40.7, 39.3, 27.6, 27.3, 25.9. HRMS (ESI): calculated for C30H37N4O3 [M+H]+: 501.2860, found 501.2844.

Light yellow solid, 146 mg, 62% yield, mp = 167−168 °C, [a]D25 = −25.5 (c = 0.33, CHCl3). 1H NMR (300 MHz, CD3OD) δ 8.77 (d, J = 4.7 Hz, 1H), 8.01 (d, J = 9.2 Hz, 1H), 7.65 (d, J = 15.0 Hz, 3H), 4672

DOI: 10.1021/acs.joc.7b00306 J. Org. Chem. 2017, 82, 4668−4676

Article

The Journal of Organic Chemistry

(m, 2H), 5.75 (d, J = 9.9 Hz, 1H), 5.61 (t, J = 9.4 Hz, 1H), 4.72 (d, J = 9.4 Hz, 1H), 3.80 (s, 3H), 1.25 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-1-(3-chlorophenyl)-2-nitro-2-phenylethyl]carbamate (6ea). White solid, 37.3 mg, 99% yield, dr = 99:1, mp = 192−194 °C, [a]D20 = 33.6 (c = 0.5, CHCl3), The ee value was 98% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 12.34 min, tminor = 13.47 min), Minor-syn-(tmajor = 16.28 min, tminor = 9.81 min)]. 1H NMR (300 MHz, CDCl3) δ 7.60− 7.49 (m, 2H), 7.47−7.39 (m, 3H), 7.37−7.28 (m, 3H), 7.25−7.21 (m, 1H), 5.71 (dd, J = 18.0 Hz, 2H), 4.85 (br, 1H), 1.26 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 154.19, 139.60, 134.87, 131.18, 130.39, 130.27, 128.97, 128.65, 127.44, 125.51, 93.93, 80.71, 56.33, 28.05. HRMS (ESI): calculated for C19H21ClN2NaO4+ ([M+Na]+) 399.1082. Found 399.1080. Absolute and relative configurations were assigned on the analogy of 6aa. tert-Butyl [(1S,2R)-1-(4-fluorophenyl)-2-nitro-2-phenylethyl]carbamate (6fa). White solid, 36 mg, 99% yield, dr = 98:2, mp = 191−193 °C, [a]D20 = 82.8 (c = 0.5, CHCl3), The ee value was 98% [Chiralpak IA-3, hexane/EtOH = 95:5, 230 nm, 1.0 mL/min, Majoranti(tmajor = 13.39 min, tminor = 12.74 min), Minor-syn-(tmajor = 15.60 min, tminor = 25.46 min)]. 1H NMR (300 MHz, CDCl3) δ 7.63− 7.50 (m, 2H), 7.49−7.38 (m, 3H), 7.34 (dd, J = 8.6, 5.2 Hz, 2H), 7.14−6.98 (m, 2H), 5.76 (d, J = 10.1 Hz, 1H), 5.65 (d, J = 9.1 Hz, 1H), 4.79 (d, J = 8.8 Hz, 1H), 1.26 (s, 9H). 19F NMR (376 MHz, CDCl3) δ −112.7. Analytical and spectral data were in agreement with the literature data.7 tert-Butyl [(1S,2R)-1-(4-chlorophenyl)-2-nitro-2-phenylethyl]carbamate (6ga). White solid, 37.4 mg, 99% yield, dr = 99:1, m.p.=196−197 °C, [a]D20 = 24.8 (c = 0.5, CHCl3), The ee value was 99% [Chiralpak AD-H, hexane/i-PrOH = 90:10, 214 nm, 1.0 mL/min, Major-anti(tmajor = 21.14 min, tminor = 35.13 min), Minor-syn-(tmajor = 32.27 min, tminor = 22.89 min)]. 1H NMR (300 MHz, CDCl3) δ 7.59− 7.49 (m, 2H), 7.48−7.38 (m, 3H), 7.38−7.26 (m, 4H), 5.76 (d, J = 9.8 Hz, 1H), 5.62 (d, J = 9.2 Hz, 1H), 4.76 (d, J = 9.0 Hz, 1H), 1.26 (s, 9H). Analytical and spectral data were in agreement with the literature data.7 tert-Butyl [(1S,2R)-1-(4-boranylphenyl)-2-nitro-2-phenylethyl]carbamate (6ha). White solid, 40.8 mg, 97% yield, dr = 99:1, m.p.=189−190 °C, [a]D20 = 38 (c = 0.3, CHCl3), The ee value was 99% [Chiralpak AD-H, hexane/i-PrOH = 95:5, 210 nm, 1.0 mL/min, Major-anti(tmajor = 41.54 min, tminor = 29.64 min), Minor-syn-(tmajor = 55.38 min, tminor = 34.92 min)]. 1H NMR (300 MHz, CDCl3) δ 7.59− 7.46 (m, 4H), 7.46−7.38 (m, 3H), 7.30−7.18 (m, 2H), 5.75 (d, J = 9.3 Hz, 1H), 5.61 (br, 1H), 4.81 (br, 1H), 1.26 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-2-nitro-2-phenyl-1-(p-tolyl)ethyl]carbamate (6ia). White solid, 35.4 mg, 99% yield, dr = 99:1, m.p.=190− 192 °C, [a]D20 = 31.2 (c = 0.5, CHCl3), The ee value was 96% [Chiralpak AD-H, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 15.66 min, tminor = 14.40 min), Minor-syn-(tmajor = 24.43 min, tminor = 11.97 min)]. 1H NMR (300 MHz, CDCl3) δ 7.61− 7.52 (m, 2H), 7.49−7.35 (m, 3H), 7.28−7.20 (m, 2H), 7.17 (d, J = 8.2 Hz, 1H), 5.75 (d, J = 10.1 Hz, 1H), 5.64 (br, 1H), 4.76 (d, J = 9.4 Hz, 1H), 2.34 (s, 3H), 1.24 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-1-(4-methoxyphenyl)-2-nitro-2-phenylethyl]carbamate (6ja). White solid, 37.1 mg, 99% yield, dr = 99:1, mp = 191−193 °C, [a]D20 = 49.6 (c = 0.5, CHCl3), The ee value was 98% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 18.74 min, tminor = 60.96 min), Minor-syn-(tmajor = 33.19 min, tminor = 20.76 min)]. 1H NMR (300 MHz, CDCl3) δ 7.65− 7.52 (m, 2H), 7.42 (dd, J = 5.1, 2.0 Hz, 3H), 7.34−7.25 (m, 1H), 6.93 (d, J = 7.8 Hz, 1H), 6.90−6.82 (m, 2H), 5.76 (d, J = 9.9 Hz, 1H), 5.68 (d, J = 9.0 Hz, 1H), 4.75 (d, J = 9.0 Hz, 1H), 3.80 (s, 3H), 1.25 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-2-nitro-2-phenyl-1-(4-(trifluoromethyl)phenyl)ethyl]carbamate (6ka). White solid, 41.0 mg, 99% yield, dr = 99:1, mp = 191−193 °C, [a]D20 = 54.8 (c = 0.5, CHCl3), The ee value was

7.55−7.43 (m, 1H), 7.29 (s, 2H), 7.14 (d, J = 6.9 Hz, 2H), 6.94 (d, J = 7.4 Hz, 3H), 6.31 (d, J = 10.6 Hz, 1H), 5.99−5.87 (m, 1H), 5.28−5.13 (m, 2H), 5.03−4.92 (m, 2H), 4.88−4.78 (m, 1H), 4.40 (br, 1H), 4.19 (br, 1H), 4.07 (s, 3H), 3.77−3.53 (m, 2H), 3.48 (dd, J = 10.0, 4.4 Hz, 2H), 3.42−3.32 (m, 2H), 3.13 (s, 3H), 2.71 (d, J = 6.2 Hz, 1H), 2.26− 1.93 (m, 4H), 1.88 (br, 2H), 1.33 (s, 18H). 13C NMR (75 MHz, CD3OD) δ 160.8, 158.8, 153.4, 148.7, 146.0, 145.8, 141.9, 138.0, 132.1, 129.4, 129.1, 128.8, 128.3, 127.9, 127.3, 125.9, 124.3, 120.8, 118.3, 102.7, 77.0, 70.2, 68.2, 61.5, 59.2, 56.7, 55.5, 51.4, 50.4, 38.7, 36.0, 31.9, 29.2, 28.3, 25.8. HRMS (ESI): calculated for C45H59N4O3 [M−Br]+: 703.4582, found 703.4569. General Procedure for Enantio- and Diastereoselective Nitro-Mannich Reaction. Without protection of inert gases, catalyst 2b (5 mol%) and amidosulfones (0.10 mmol) were dissolved in dry chloroform (1.0 mL), α-aryl nitromethane (0.15 mmol, 1.5 equiv) was added, the mixture was cooled to −40 °C, freshly grounded LiOH (12.0 mg, 5 equiv) was added in one portion, and the resulting suspension was vigorously stirred at −40 °C. After 12 h, 5 mL sat. aq. NH4Cl was added and the solution was allowed to warm to room temperature, the aqueous was extracted with ethyl acetate (3 × 5 mL), then the organic layer was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by flash chromatography (PE/EA = 10:1). Synthesis of Racemates. Without protection of inert gases, amidosulfones (0.10 mmol) were dissolved in dry chloroform (1.0 mL), α-aryl nitromethane (0.15 mmol, 1.5 equiv) was added, the mixture was stirred at room temperature, and DBU(20 mol%) was added. After 12 h, 5 mL sat. aq. NH4Cl was added, the aqueous was extracted with ethyl acetate (3 × 5 mL), then the organic layer was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by flash chromatography (PE/EA = 10:1). tert-Butyl [(1S,2R)-2-nitro-1,2-diphenylethyl]carbamate (6aa). White solid, 34 mg, 99% yield, dr = 99:1, mp = 198−200 °C, [a]D20 = 49.2 (c = 0.5, CHCl3), The ee value was 99% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 17.74 min, tminor = 16.11 min), Minor-syn-(tmajor = 25.23 min, tminor = 12.24 min)]. 1H NMR (300 MHz, CDCl3) δ 7.62−7.52 (m, 3H), 7.49−7.39 (m, 3H), 7.38−7.24 (m, 4H), 5.74 (br, 1H), 5.63 (br, 1H), 4.84 (s, 1H), 1.26 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-1-(2-fluorophenyl)-2-nitro-2-phenylethyl]carbamate (6ba). White solid, 35.8 mg, 99% yield, dr = 99:1, mp = 181−183 °C, [a]D20 = 56.8 (c = 0.5, CHCl3), The ee value was 99% [Chiralpak IC-3, hexane/EtOH = 16:1, 210 nm, 0.5 mL/min, Major-anti(tmajor = 12.12 min, tminor = 13.27 min), Minor-syn-(tmajor = 18.67 min, tminor = 15.16 min)]. 1H NMR (300 MHz, CDCl3) δ7.63 (dd, J = 6.5, 3.1 Hz, 2H), 7.53−7.29 (m, 5H), 7.21−7.02 (m, 2H), 5.87 (d, J = 3.6 Hz, 2H), 5.07 (br, 1H), 1.22 (s, 9H). 19F NMR (376 MHz, CDCl3) δ −117.2 Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-1-(2-methoxyphenyl)-2-nitro-2-phenylethyl]carbamate (6ca). White solid, 37 mg, 99% yield, dr = 99:1, mp = 185−187 °C, [a]D20 = 59.2 (c = 0.5, CHCl3), The ee value was 98% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 8.73 min, tminor = 27.67 min), Minor-syn-(tmajor = 10.06 min, tminor = 17.63 min)]. 1H NMR (300 MHz, CDCl3) δ 7.64 (s, 2H), 7.40 (s, 3H), 7.35−7.22 (m, 2H), 7.02−6.83 (m, 2H), 5.99 (d, J = 7.2 Hz, 1H), 5.81 (t, J = 10.4 Hz, 1H), 5.51 (d, J = 10.4 Hz, 1H), 3.98 (s, 3H), 1.20 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 157.2, 154.4, 132.0, 131.5, 130.1, 129.9, 128.96, 128.5, 124.4, 121.3, 111.2, 93.2, 79.7, 55.9, 55.6, 28.1. HRMS (ESI): calculated for C20H24N2O5Na+ ([M+Na]+) 395.1577. Found 395.1577. Absolute and relative configurations were assigned on the analogy of 6aa. tert-Butyl [(1S,2R)-1-(3-methoxyphenyl)-2-nitro-2-phenylethyl]carbamate (6da). White solid, 37.1 mg, 99% yield, dr = 93:7, mp = 177−178 °C, [a]D20 = 43 (c = 0.4, CHCl3), The ee value was 98% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 21.75 min, tminor = 31.58 min), Minor-syn-(tmajor = 18.77 min, tminor = 16.02 min)]. 1H NMR (300 MHz, CDCl3) δ 7.64− 7.51 (m, 2H), 7.47−7.35 (m, 3H), 7.32−7.22 (m, 2H), 6.95−6.82 4673

DOI: 10.1021/acs.joc.7b00306 J. Org. Chem. 2017, 82, 4668−4676

Article

The Journal of Organic Chemistry

(d, J = 9.2 Hz, 1H), 1.23 (s, 9H). 19F NMR (376 MHz, CDCl3) δ −117.9. Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-2-(3-methoxyphenyl)-2-nitro-1-phenylethyl]carbamate (6ac). White solid, 37.1 mg, 90% yield, dr = 99:1, mp = 179−181 °C, [a]D20 = 22 (c = 0.5, CHCl3), The ee value was 98% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, Major-anti(tmajor = 40.56 min, tminor = 20.92 min), Minor-syn-(tmajor = 22.33 min, tminor = 16.54 min)]. 1H NMR (300 MHz, CDCl3) δ 7.43−7.27 (m, 6H), 7.17−7.08 (m, 2H), 7.01−6.92 (m, 1H), 5.73 (t, J = 13.6 Hz, 2H), 4.77 (br, 1H), 3.83 (s, 3H), 1.27 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-2-(4-bromophenyl)-2-nitro-1-phenylethyl)carbamate (6ad). White solid, 42.1 mg, 99% yield, dr = 98:2, mp = 169−171 °C, [a]D20 = 29.6 (c = 0.5, CHCl3), The ee value was 99% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 16.20 min, tminor = 20.86 min), Minor-syn-(tmajor = 43.19 min, tminor = 12.67 min)]. 1H NMR (300 MHz, CDCl3) δ 7.55 (d, J = 8.0 Hz, 2H), 7.46 (d, J = 7.9 Hz, 2H), 7.41−7.22 (m, 5H), 5.74 (br, 1H), 5.63 (br, 1H), 4.85 (br, 1H), 1.27 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-2-nitro-1-phenyl-2-(p-tolyl)ethyl]carbamate (6ae). White solid, 35.5 mg, 99% yield, dr = 99:1, mp = 184− 186 °C, [a]D20 = 91.6 (c = 0.5, CHCl3), The ee value was 99% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 16.32 min, tminor = 15.14 min), Minor-syn-(tmajor = 25.18 min, tminor = 11.36 min)]. 1H NMR (300 MHz, CDCl3) δ 7.44 (d, J = 8.2 Hz, 2H), 7.40−7.30 (m, 5H), 7.21 (d, J = 7.9 Hz, 2H), 5.73 (d, J = 9.9 Hz, 1H), 5.66 (d, J = 8.4 Hz, 1H), 4.76 (br, 1H), 2.37 (s, 3H), 1.26 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-2-(4-methoxyphenyl)-2-nitro-1-phenylethyl]carbamate (6af). White solid, 37.1 mg, 99% yield, dr = 99:1, mp = 181−182 °C, [a]D20 = 38.8 (c = 0.5, CHCl3), The ee value was 91% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 22.83 min, tminor = 19.13 min), Minor-syn-(tmajor = 37.92 min, tminor = 15.12 min)]. 1H NMR (300 MHz, CDCl3) δ 7.58− 7.48 (m, 2H), 7.43−7.32 (m, 5H), 7.00−6.89 (m, 2H), 5.72 (t, J = 13.3 Hz, 2H), 4.79 (br, 1H), 3.85 (s, 3H), 1.30 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-2-(naphthalen-2-yl)-2-nitro-1-phenylethyl]carbamate (6ag). White solid, 39.1 mg, 99% yield, dr = 98:2, mp = 183−186 °C, [a]D20 = 45.6 (c = 0.5, CHCl3), The ee value was 96% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 30.77 min, tminor = 25.86 min),Minor-syn-(tmajor = 35.52 min, tminor = 14.65 min)]. 1H NMR (300 MHz, CDCl3) δ 8.03 (s, 1H), 7.93−7.81 (m, 3H), 7.69 (d, J = 8.5 Hz, 1H), 7.59−7.48 (m, 2H), 7.44−7.33 (m, 5H), 5.97 (d, J = 9.9 Hz, 1H), 5.78 (br, 1H), 4.80 (d, J = 8.5 Hz, 1H), 1.16 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-2-(2-fluorophenyl)-1-(4-methoxyphenyl)-2nitroethyl]carbamate (6jb). White solid, 38.5 mg, 98% yield, dr = 99:1, mp = 145−146 °C, [a]D20 = 72 (c = 0.35, CHCl3), The ee value was 98% [Chiralpak IA-3, hexane/i-PrOH = 10:1, 210 nm, 1.0 mL/min, Major-anti(tmajor = 18.52 min, tminor = 16.50 min)]. 1H NMR (400 MHz, CDCl3) δ 7.79 (t, J = 7.3 Hz, 1H), 7.46−7.36 (m, 1H), 7.30 (t, J = 7.9 Hz, 1H), 7.23 (d, J = 7.7 Hz, 1H), 7.16−7.09 (m, 1H), 6.95 (d, J = 7.6 Hz, 1H), 6.88 (d, J = 8.3 Hz, 2H), 6.19 (d, J = 10.3 Hz, 1H), 5.70 (br, 1H), 4.82 (br, 1H), 3.81 (s, 3H), 1.23 (s, 9H). 19 F NMR (376 MHz, CDCl3) δ −117.8. Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-2-(4-bromophenyl)-1-(4-methoxyphenyl)-2nitroethyl]carbamate (6jd). White solid, 45.1 mg, 99% yield, dr = 97:3, mp = 181−182 °C, [a]D20 = 37 (c = 0.6, CHCl3), The ee value was 96% [Chiralpak IA-3, hexane/i-PrOH = 80:20, 254 nm, 1.0 mL/min, Major-anti(tmajor = 9.68 min, tminor = 36.58 min),Minorsyn-(tmajor = 26.66 min, tminor = 10.57 min)]. 1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 8.3 Hz, 2H), 7.46 (d, J = 8.3 Hz, 2H), 7.30 (d, J = 7.8 Hz, 1H), 6.89 (dd, J = 12.5, 7.8 Hz, 3H), 5.74 (d, J = 9.6 Hz, 1H), 5.61 (br, 1H), 4.76 (d, J = 9.4 Hz, 1H), 3.80 (s, 3H), 1.27

98% [Chiralpak IA-3, hexane/i-PrOH = 95:5, 210 nm, 1.0 mL/min, Major-anti(tmajor = 37.53 min, tminor = 23.85 min), Minor-syn-(tmajor = 47.90 min, tminor = 33.23 min)]. 1H NMR (300 MHz, CDCl3) δ 7.63 (d, J = 8.2 Hz, 2H), 7.58−7.52 (m, 2H), 7.52−7.38 (m, 5H), 5.79 (s, 1H), 5.73 (d, J = 8.6 Hz, 1H), 4.82 (d, J = 8.9 Hz, 1H), 1.26 (s, 9H). 19 F NMR (376 MHz, CDCl3) δ −62.7. Analytical and spectral data were in agreement with the literature data.7 tert-Butyl [(1S,2R)-2-nitro-1-(4-nitrophenyl)-2-phenylethyl]carbamate (6la). White solid, 36.0 mg, 93% yield, dr = 94:6, mp = 187−188 °C, [a]D20 = 22 (c = 0.4, CHCl3), The ee value was 99% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 24.73 min, tminor = 20.13 min), Minor-syn-(tmajor = 36.53 min, tminor = 27.63 min)]. 1H NMR (400 MHz, CDCl3) δ 8.28− 8.19 (m, 2H), 7.60−7.51 (m, 4H), 7.50−7.41 (m, 3H), 5.83 (br, 1H), 5.72 (t, J = 8.9 Hz, 1H), 4.88 (d, J = 8.5 Hz, 1H), 1.27 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 154.2, 148.0, 144.7, 130.8, 130.7, 129.2, 128.5, 128.4, 124.1, 93.5, 81.1, 56.3, 28.1. HRMS (ESI): calculated for C19H21N3NaO6+ ([M+Na]+) 410.1323. Found 410.1330. Absolute and relative configurations were assigned on the analogy of 6aa. tert-Butyl [(1S,2R)-1-(4-cyanophenyl)-2-nitro-2-phenylethyl]carbamate (6ma). White solid, 35.7 mg, 97% yield, dr = 98:2, mp = 176−177 °C, [a]D20 = 37 (c = 0.5, CHCl3), The ee value was 95% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 21.34 min, tminor = 19.77 min), Minor-syn-(tmajor = 32.67 min, tminor = 27.95 min)]. 1H NMR (400 MHz, CDCl3) δ 7.67 (d, J = 8.1 Hz, 2H), 7.60−7.39 (m, 7H), 5.79 (br, 1H), 5.68 (d, J = 8.1 Hz, 1H), 4.90 (br, 1H), 1.27 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 154.2, 142.8, 132.7, 130.8, 130.6, 129.2, 128.5, 128.2, 118.2, 112.8, 93.5, 81.0, 52.1, 28.0. HRMS (ESI): calculated for C20H21N3NaO4+ ([M+Na]+) 390.1424. Found 390.1425. Absolute and relative configurations were assigned on the analogy of 6aa. tert-Butyl [(1S,2R)-1-(naphthalen-2-yl)-2-nitro-2-phenylethyl]carbamate (6na). White solid, 35.3 mg, 90% yield, dr = 99:1, mp = 190−191 °C, [a]D20 = 23.5 (c = 0.4, CHCl3), The ee value was 97% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 1.0 mL/min, Major-anti(tmajor = 23.21 min, tminor = 17.95 min), Minor-syn-(tmajor = 28.97 min, tminor = 14.68 min)]. 1H NMR (300 MHz, CDCl3) δ 7.93− 7.74 (m, 4H), 7.68−7.56 (m, 2H), 7.55−7.36 (m, 6H), 5.89 (s, 2H), 4.89 (d, J = 8.1 Hz, 1H), 1.25 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1R,2R)-1-(furan-2-yl)-2-nitro-2-phenylethyl]carbamate (6oa). White solid, 33 mg, 99% yield, dr = 98:2, mp = 163−165 °C, [a]D20 = 44.8 (c = 0.5, CHCl3), The ee value was 99% [Chiralpak IC-3, hexane/i-PrOH = 98:2, 210 nm, 1.0 mL/min, Majoranti(tmajor = 22.69 min, tminor = 35.67 min), Minor-syn-(tmajor = 47.19 min, tminor = 40.83 min)]. 1H NMR (300 MHz, CDCl3) δ 7.60− 7.49 (m, 2H), 7.46−7.33 (m, 4H), 6.34 (d, J = 1.3 Hz, 2H), 5.83 (s, 2H), 4.88 (br, 1H), 1.26 (s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1R,2R)-2-nitro-2-phenyl-1-(thiophen-2-yl)ethyl]carbamate (6pa). White solid, 34.7 mg, 99% yield, dr = 97:3, mp = 166−167 °C, [a]D20 = 38.4 (c = 0.5, CHCl3), The ee value was 92% [Chiralpak IC-3, hexane/EtOH = 16:1, 210 nm, 0.5 mL/min, Major-anti(tmajor = 13.77 min, tminor = 15.11 min), Minor-syn-(tmajor = 19.71 min, tminor = 17.53 min)]. 1H NMR (300 MHz, CDCl3) δ 7.61−7.48 (m, 2H), 7.47−7.35 (m, 3H), 7.33−7.21 (m, 1H), 7.06 (d, J = 3.4 Hz, 1H), 6.97 (dd, J = 5.1, 3.6 Hz, 1H), 5.95 (d, J = 9.4 Hz, 1H), 5.86 (d, J = 9.6 Hz, 1H), 4.79 (br, 1H), 1.28 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 154.1, 140.4, 131.5, 130.2, 128.9, 128.6, 127.1, 126.4, 125.8, 94.5, 80.6, 52.6, 28.1. HRMS (ESI): calculated for C17H20N2NaO4S+ ([M+Na]+) 371.1036. Found 371.1034. Absolute and relative configurations were assigned on the analogy of 6aa. tert-Butyl [(1S,2R)-2-(2-fluorophenyl)-2-nitro-1-phenylethyl]carbamate (6ab). White solid, 33.8 mg, 94% yield, dr = 93:7, mp = 175−176 °C, [a]D20 = 25.6 (c = 0.5, CHCl3), The ee value was 99% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 0.5 mL/min, Major-anti(tmajor = 33.81 min, tminor = 17.89 min), Minor-syn-(tmajor = 27.08 min, tminor = 19.56 min)]. 1H NMR (300 MHz, CDCl3) δ 7.80 (t, J = 7.0 Hz, 1H), 7.37 (s, 6H), 7.27−7.18 (m, 1H), 7.12 (t, J = 9.3 Hz, 1H), 6.21 (d, J = 10.4 Hz, 1H), 5.72 (br, 1H), 4.90 4674

DOI: 10.1021/acs.joc.7b00306 J. Org. Chem. 2017, 82, 4668−4676

Article

The Journal of Organic Chemistry

(1R,2S)-1,2-Diphenylethane-1,2-diamine (8aa). White solid, 19.3 mg, 97% yield, 1H NMR (300 MHz, CDCl3) δ 7.34−7.16 (m, 10H), 4.10 (s, 2H), 1.55 (s, 4H). 13C NMR (101 MHz, CDCl3) δ 143.5, 128.2, 127.0, 126.9, 61.9. HRMS (ESI): calculated for C14H17N2 [M +H]+: 213.1386, found 213.1380. (1S,2R)-1-(3-Chlorophenyl)-2-phenylethane-1,2-diamine (8ea). White solid, 22.9 mg, 94% yield, [a]D20 = 89 (c = 0.5, CHCl3), The ee value was 98% [Chiralpak IC-3, hexane/i-PrOH/EtOH = 80:14:6, 254 nm, 0.5 mL/min, Major-anti(tmajor = 12.21 min, tminor = 12.76 min).1H NMR (300 MHz, CDCl3) δ = 7.57−7.00 (m, 9H), 4.12−3.89 (m, 2H), 1.51 (br, 4H). 13C NMR (75 MHz, CDCl3) δ 145.3, 142.6, 134.5, 129.7, 128.6, 127.9, 127.6, 127.7, 127.65, 126.1, 62.8, 62.5. HRMS (ESI): calculated for C14H16ClN2 [M+H]+: 247.0997, found 247.1002.

(s, 9H). Analytical and spectral data were in agreement with the literature data.8 tert-Butyl [(1S,2R)-1,2-bis(4-bromophenyl)-2-nitroethyl]carbamate (6hd). White solid, 50 mg, 99% yield, dr = 97:3, mp = 183−185 °C, [a]D20 = −13.2 (c = 0.5, CHCl3), The ee value was 99% [Chiralpak IA-3, hexane/EtOH = 90:5, 230 nm, 1.0 mL/min, Major-anti(tmajor = 23.64 min, tminor = 15.92 min), Minor-syn-(tmajor = 69.55 min, tminor = 29.89 min)]. 1H NMR (300 MHz, CDCl3) δ 7.63− 7.53 (m, 2H), 7.53−7.47 (m, 2H), 7.43 (d, J = 8.6 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 5.74 (d, J = 9.5 Hz, 1H), 5.56 (t, J = 9.6 Hz, 1H), 4.82 (br, 1H), 1.28 (s, 9H). Analytical and spectral data were in agreement with the literature data.7 tert-Butyl [(1R,2S)-1-nitro-1,4-diphenylbutan-2-yl]carbamate (6oa). White solid, 34 mg, 91% yield, dr = 94:6, mp = 133−134 °C, [a]D20 = 10.4 (c = 0.5, CHCl3), The ee value was 97% [Chiralpak AD-H, hexane/i-PrOH = 95:5, 210 nm, 1.0 mL/min, Major-anti(tmajor = 26.57 min, tminor = 38.17 min), Minor-syn-(tmajor = 33.70 min, tminor = 42.41 min)]. 1H NMR (300 MHz, CDCl3) δ 7.46−7.34 (m, 5H), 7.30 (d, J = 6.8 Hz, 1H), 7.21 (d, J = 6.9 Hz, 1H), 7.14 (d, J = 6.8 Hz, 2H), 5.65 (s, 1H), 4.55−4.27 (m, 2H), 2.89−2.74 (m, 1H), 2.72−2.56 (m, 1H), 1.94 (br, 2H), 1.33 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 155.0, 140.7, 132.2, 129.9, 128.9, 128.7, 128.5, 128.4, 126.3, 93.7, 80.1, 53.3, 32.8, 32.3, 28.3. HRMS (ESI): calculated for C21H26N2O4Na+ ([M+Na]+) 393.1785. Found 393.1777. Absolute and relative configurations were assigned on the analogy of 6aa. Derivatization of 6aa and 6ea. To a solution of 6aa (34.2 mg, 0.10 mmol) in anhydrous MeOH (0.5 mL) was added NiCl2·6H2O (23.8 mg, 0.10 mmol) at room temperature. The mixture solution was cooled to 0 °C before NaBH4 (56.7 mg, 1.50 mmol) was added in portions. The reaction mixture was then stirred for 2 h and poured into a saturated aqueous solution of NH4Cl. The aqueous phase was extracted with ethyl acetate (5 mL) twice. The combined organic phases were washed with brine and dried over Na2SO4 and filtered. After concentration, the resulting residue was purified by column chromatography on silica gel (PE/EA = 2:1 as eluent) to give 7aa. To a solution of 7aa (31.2 mg, 0.10 mmol) in anhydrous CH2Cl2 (0.15 mL) was added trifluoroacetic acid (0.15 mL) at 0 °C. The reaction mixture was then stirred for 2 h and poured into an ice-cooled 1 N aqueous solution of NaOH. The aqueous phase was extracted with CH2Cl2 (5 mL) twice. The combined organic phases were washed with brine, dried over MgSO4, and filtered. After concentration, the resulting residue was purified by column chromatography on silica gel (PE/EA = 1:2 as eluent) to give 8aa. Determination of the ee Value of 8ea. To a solution of 8ea (5 mg, 1 equiv) in anhydrous CH2Cl2 (1 mL) was added Et3N (6 μL, 2 equiv) and m-toluoyl chloride (3 μL, 1.1 equiv) at rt. The reaction mixture was then stirred for 20 min and poured into a saturated aqueous solution of NH4Cl. Take 100 μL of the organic phase. After concentration, it was dissolved in 1 mL of isopropanol and determination was done by HPLC. tert-Butyl [(1S,2R)-2-amino-1,2-diphenylethyl]carbamate (7aa). White solid, 25.6 mg, 82% yield, dr = 99:1, [a]D20 = 67 (c = 0.35, CHCl3), The ee value was 99% [Chiralpak AD-H, hexane/i-PrOH = 97:3, 210 nm, 1.0 mL/min, Major-anti(tmajor = 10.44 min, tminor = 11.58 min). 1H NMR (300 MHz, DMSO-d6) δ 7.46−7.06 (m, 12H), 4.54 (t, J = 8.8 Hz, 1H), 3.97 (d, J = 8.4 Hz, 1H), 1.60 (br, 2H), 1.18 (s, 9H). 13C NMR (101 MHz, DMSO-d6) δ 154.5, 143.9, 141.4, 127.8, 127.6, 127.5, 126.8, 126.5, 99.5, 77.5, 60.8, 59.6, 28.1. HRMS (ESI): calculated for C19H25N2O2 [M+H]+: 313.1911, found 313.1903. tert-Butyl [(1S,2R)-2-amino-1-(3-chlorophenyl)-2 phenylethyl]carbamate (7ea). White solid, 26 mg, 75% yield, dr = 98:2, [a]D20 = −17 (c = 0.2, CHCl3), The ee value was 98% [Chiralpak IA-3, hexane/i-PrOH = 90:10, 210 nm, 0.5 mL/min, Major-anti(tmajor = 20.39 min, tminor = 22.88 min). 1H NMR (300 MHz, CD3OD) δ 7.43− 7.19 (m, 9H), 4.85 (br, 1H), 4.79 (d, J = 7.8 Hz, 1H), 4.11 (d, J = 8.7 Hz, 1H), 1.27 (s, 9H). 13C NMR (75 MHz, CD3OD) δ 157.1, 144.0, 142.3, 135.4, 131.0, 129.4, 129.1, 128.9, 128.8, 128.7, 127.2, 80.4, 61.5, 61.0, 28.6. HRMS (ESI): calculated for C19H24ClN2O2 [M +H]+: 347.1521, found 347.1521.

■

ASSOCIATED CONTENT

S Supporting Information *

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.joc.7b00306. Detailed experimental procedures including complete characterizations (1H NMR and 13C NMR spectra, spectral data, and HRMS) (PDF)

■

AUTHOR INFORMATION

Corresponding Authors

*E-mail: [email protected]. *E-mail: [email protected]. ORCID

Ning Lu: 0000-0003-1424-5714 Notes

The authors declare no competing financial interest.

■

ACKNOWLEDGMENTS We give thanks for the financial support from the National Natural Science Foundation of China (No. 51373067) and Science and Technology Development Project of Jilin Province (No. 20140520085JH).

■

REFERENCES

(1) (a) Kizirian, J.-C. Chem. Rev. 2008, 108, 140−205. (b) Lucet, D.; Le Gall, T.; Mioskowski, C. Angew. Chem., Int. Ed. 1998, 37, 2580− 2627. (c) Ghosh, U.; Ganessunker, D.; Sattigeri, V. J.; Carlson, K. E.; Mortensen, D. J.; Katzenellenbogen, B. S.; Katzenellenbogen, J. A. Bioorg. Med. Chem. 2003, 11, 629−657. (d) Saibabu Kotti, S. R. S.; Timmons, C.; Li, G. Chem. Biol. Drug Des. 2006, 67, 101−114. (2) (a) Kim, H.; Nguyen, Y.; Yen, C. P.-H.; Chagal, L.; Lough, A. J.; Kim, B. M.; Chin, J. J. Am. Chem. Soc. 2008, 130, 12184−12191. (b) Kise, N.; Ueda, N. Tetrahedron Lett. 2001, 42, 2365−2368. (c) Zhong, Y.-W.; Izumi, K.; Xu, M.-H.; Lin, G.-Q. Org. Lett. 2004, 6, 4747−4750. (d) Tamura, K.; Kumagai, N.; Shibasaki, M. Eur. J. Org. Chem. 2015, 2015, 3026−3031. (e) Roskamp, E. J.; Pedersen, S. F. J. Am. Chem. Soc. 1987, 109, 3152−3154. (3) (a) Cardona, F.; Goti, A. Nat. Chem. 2009, 1, 269−275. (b) Funk, T. W.; Berlin, J. M.; Grubbs, R. H. J. Am. Chem. Soc. 2006, 128, 1840−1846. (c) Surry, D. S.; Buchwald, S. L. Chem. Sci. 2010, 1, 13−31. (d) Miyazaki, M.; Uoto, K.; Sugimoto, Y.; Naito, H.; Yoshida, K.; Okayama, T.; Kawato, H.; Miyazaki, M.; Kitagawa, M.; Seki, T.; Fukutake, S.; Aonuma, M.; Soga, T. Bioorg. Med. Chem. 2015, 23, 2360−2367. (4) (a) Proskurnina, M. V.; Lozinskaya, N. A.; Tkachenko, S. E.; Zefirov, N. S. Russ. J. Org. Chem. 2002, 38, 1149−1153. (b) Hatano, B.; Ogawa, A.; Hirao, T. J. Org. Chem. 1998, 63, 9421−9424. (c) De, C. K.; Seidel, D. J. Am. Chem. Soc. 2011, 133, 14538−14541. (5) (a) Davis, T. A.; Vilgelm, A. E.; Richmond, A.; Johnston, J. N. J. Org. Chem. 2013, 78, 10605−10616. (b) Vara, B. A.; Mayasundari, A.; 4675

DOI: 10.1021/acs.joc.7b00306 J. Org. Chem. 2017, 82, 4668−4676

Article

The Journal of Organic Chemistry Tellis, J. C.; Danneman, M. W.; Arredondo, V.; Davis, T. A.; Min, J.; Finch, K.; Guy, R. K.; Johnston, J. N. J. Org. Chem. 2014, 79, 6913− 6938. (c) Walvoord, R. R.; Kozlowski, M. C. Tetrahedron Lett. 2015, 56, 3070−3074. (d) Westermann, B. Angew. Chem., Int. Ed. 2003, 42, 151−153. (6) (a) Marqués-López, E.; Merino, P.; Tejero, T.; Herrera, R. P. Eur. J. Org. Chem. 2009, 2009, 2401−2420. (b) Noble, A.; Anderson, J. C. Chem. Rev. 2013, 113, 2887−2939. (c) Fini, F.; Sgarzani, V.; Pettersen, D.; Herrera, R. P.; Bernardi, L.; Ricci, A. Angew. Chem., Int. Ed. 2005, 44, 7975−7978. (d) Johnson, K. M.; Rattley, M. S.; Sladojevich, F.; Barber, D. M.; Nuñez, M. G.; Goldys, A. M.; Dixon, D. J. Org. Lett. 2012, 14, 2492−2495. (e) Wang, H.-Y.; Zhang, K.; Zheng, C.-W.; Chai, Z.; Cao, D.-D.; Zhang, J.-X.; Zhao, G. Angew. Chem., Int. Ed. 2015, 54, 1775−1779. (7) Davis, T. A.; Johnston, J. N. Chem. Sci. 2011, 2, 1076−1079. (8) Uraguchi, D.; Oyaizu, K.; Noguchi, H.; Ooi, T. Chem. - Asian J. 2015, 10, 334−337. (9) For unfavorable effect of external bases on the diastereo- and enantioselectivity of asymmetric reaction, see: (a) Liu, Y.; Wang, X.; Wang, X.; He, W. Org. Biomol. Chem. 2014, 12, 3163−3166. (b) Ma, C.-H.; Kang, T.-R.; He, L.; Liu, Q.-Z. Eur. J. Org. Chem. 2014, 2014, 3981−3985. (10) (a) Cao, D.; Chai, Z.; Zhang, J.; Ye, Z.; Xiao, H.; Wang, H.; Chen, J.; Wu, X.; Zhao, G. Chem. Commun. 2013, 49, 5972−5974. (b) Jiang, X.; Zhang, Y.; Wu, L.; Zhang, G.; Liu, X.; Zhang, H.; Fu, D.; Wang, R. Adv. Synth. Catal. 2009, 351, 2096−2100. (c) Palomo, C.; Oiarbide, M.; Laso, A.; López, R. J. Am. Chem. Soc. 2005, 127, 17622− 17623. (d) Wang, H.-Y.; Chai, Z.; Zhao, G. Tetrahedron 2013, 69, 5104−5111. (e) Wang, H.-Y.; Zhang, J.-X.; Cao, D.-D.; Zhao, G. ACS Catal. 2013, 3, 2218−2221. (11) (a) Wang, B.; Liu, Y.; Sun, C.; Wei, Z.; Cao, J.; Liang, D.; Lin, Y.; Duan, H. Org. Lett. 2014, 16, 6432−6435. (b) Wang, B.; He, Y.; Fu, X.; Wei, Z.; Lin, Y.; Duan, H. Synlett 2015, 26, 2588−2592. (12) Cassani, C.; Martin-Rapun, R.; Arceo, E.; Bravo, F.; Melchiorre, P. Nat. Protoc. 2013, 8, 325−344. (13) (a) Wenzel, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 12964−12965. (b) Huang, L.; Wulff, W. D. J. Am. Chem. Soc. 2011, 133, 8892−8895. (c) Mecozzi, T.; Petrini, M. J. Org. Chem. 1999, 64, 8970−8972. (14) Walvoord, R. R.; Berritt, S.; Kozlowski, M. C. Org. Lett. 2012, 14, 4086−4089.

4676

DOI: 10.1021/acs.joc.7b00306 J. Org. Chem. 2017, 82, 4668−4676